A year ago the idea of having several vaccines ready to distribute within a year seemed insurmountable. But science prevailed and the development of the SARS-CoV2 vaccine was the fastest in history. Join us to learn how it has opened a new innovation window that we can learn from for the future – and possibly prevent the next epidemic from becoming a pandemic. Our panel of industry, scientific and frontline experts will explore recent achievements and challenges with all aspects of the vaccine, as well as the future of healthcare innovation.

HOSTS

• Carol Malysz, Executive Director, RI Bio
• Bongsup Cho, PhD, RI-INBRE

MODERATOR

• Michael Elliott, MBBS, PhD, FRACP, Chief Scientific Officer, Immunovant 

FEATURED SPEAKERS

• Michael Princiotta, PhD, Chief Scientific Officer, EpiVax Therapeutics 
• Katie Porter, Business Development Manager, EpiVax, Inc.
• Kerry LaPlante, Pharm.D., FCCP, FIDSA, PHP Department Chair & Professor of Pharmacy, URI & RI DOH Vaccine Committee 
• George Atanasov, State Government Affairs, J&J – DID THEY CONFIRM?  
• Ken Hiscoe, Director, US Government Relations/Corporate Affairs, Pfizer

This virtual event is brought to you in partnership with Venture Café, Driven:, BIO, and Rhode Island INBRE.